A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates

Kristian Brock, Lucinda Billingham, Christina Yap, Gary Middleton

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates'. Together they form a unique fingerprint.

Keyphrases

Mathematics

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience